Cardiovascular disease is the leading cause of morbidity and mortality in the United States. In addition to highly prevalent genetic dyslipidemias, many endocrinology related conditions such as diabetes, metabolic syndrome, Cushing’s syndrome, growth hormone deficiency, congenital adrenal hyperplasia, polycystic ovary syndrome, hypopituitarism (to name a few) are associated with dyslipidemia. As pediatric endocrinologists, we are at the forefront of managing dyslipidemia in children. It is crucial to establish an initiative among pediatric endocrinologists on dyslipidemia management, advocating healthier lifestyles and the selective use of lipid-lowering medications.
The Lipidology Special Interest Group is a forum for interested members to collaborate and facilitate communication and to network with colleagues interested in Lipidology in pediatrics. We intend to provide support and guidance for the pediatric endocrinology community to standardize medical management, support research initiatives through the PES and in collaborations with other organizations with similar goals; provide educational resources for training patients, physicians and fellows; and advocacy for models of care delivery and appropriate reimbursement.
¹ Chair ² BOD Liaison ³ Advisor 4 Secretary
© Copyright 2017. Pediatric Endocrine Society. All Rights Reserved.